Lilly to Seek FDA Approval for New Drug for Alzheimer Disease
Donanemab has already received a 'breakthrough therapy' designation from the FDA
Second COVID-19 Vaccine Dose Missed by More Than 10 Percent of Americans
Adults younger than 30 most likely to have missed second dose, with nearly 12 percent outside of the 42-day allowable window
Hawaii to Ease COVID-19 Rules for Fully Vaccinated Tourists
Governor recently said the state is expected to reach a 60 percent vaccination rate among all residents by July 8
Breast Cancer Prognosis No Better With Five Versus Two Years of Zoledronate
No significant difference found in disease-free survival, overall survival, distant disease-free survival for five versus two years of treatment
Current Use of Hormonal Contraceptives May Up Glaucoma Risk
Authors say risk for glaucoma is low and should not discourage use of hormonal contraceptives
Survival Up for Colon Cancer Patients in U.S. Military Health System
Survival better compared with colon cancer patients in the general U.S. population, overall and in subgroups including Black versus White race
Immunomodulation With IVIG, Glucocorticoids Examined in MIS-C
Early outcomes of two large observational studies show mixed results for the efficacy of immunomodulation with IVIG, glucocorticoids, or both
Statin Use May Cut Cancer Risk in Heart Failure Patients
Reduced risk for incident cancer and cancer-related mortality in patients with heart failure appears to depend on duration of statin use
Risk for VTE Up for IBD Patients Infected With SARS-CoV-2
Odds of VTE increased 8.15-fold according to models adjusting for recent hospitalization and steroid exposure
Heart Issues in Young COVID-19 Vaccine Recipients Rare, Usually Mild, Quickly Resolve
Group of health agencies says 'risks of being unvaccinated are far greater than any rare side effects from the vaccines'
